Antenatal care implications of population-based trends in Down syndrome birth rates by rurality and antenatal care provider, Queensland, 1990-2004

Medical Journal of Australia

Volumn 186, Issue 5, 2007, Pages 230-234

  Coory, Michael D ^a   Roselli, Timothy ^b   Carroll, Heidi J ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; INHIBIN A; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; AGED; ARTICLE; AUSTRALIA; BIRTH RATE; CONFUSION; COST EFFECTIVENESS ANALYSIS; DOWN SYNDROME; FEMALE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH EDUCATION; HEALTH STATISTICS; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PATIENT ATTITUDE; POPULATION RESEARCH; PREGNANCY TERMINATION; PRENATAL CARE; PRENATAL SCREENING; PRIVATE PRACTICE; PUBLIC HOSPITAL; TREND STUDY; URBAN RURAL DIFFERENCE;

EID: 33947239899     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2007.tb00878.x     Document Type: Article

References (23)

1. Reddy U, Mennuti M. Incorporating first-trimester Down syndrome screening studies into prenatal screening. Obstet Gynecol 2006; 107: 167-173.
2. Wapner R, Thom E, Simpson J, et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003; 349: 1405-1413.
3. Nicolaides K. Nuchal translucency and other first trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004; 191: 45-67.
4. Malone F, Canick J, Ball D, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005; 353: 2001-2011.
5. Wald N, Rodeck C, Hackshaw A, et al. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 2003; 10: 56-104.
6. Canick J, Wald N, Malone F, et al. Gestational age based performance of Down syndrome screening markers: results from the FASTER trial. Am J Obstet Gynecol 2003; 189: S116.
7. Human Genetics Society of Australasia, Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Joint HGSA/RANZCOG recommended "best practice" guidelines on antenatal screening for Down syndrome and other fetal aneuploidy Melbourne: HGSA, RANZCOG, 2004. http://www.ranzcog.edu.au/publications/statements/C-obs4.pdf (accessed Nov 2006).
8. Health Information Centre. Manual for the Queensland perinatal data collection. Brisbane: Queensland Health, 2005.
9. Wald N, Rodeck C, Hackshaw A, Rudnicka A. SURUSS in perspective. BJOG 2004; 111: 521-531.
10. American College of Obstetricians and Gynecologists. ACOG issues position on first-trimester screening methods [media release]. Washington: ACOG, 2004. http://www.acog.org/from_home/publications/ press_releases/nr06-30-04.cfm (accessed Nov 2006).
11. National Institute of Clinical Excellence. Routine care for healthy pregnant women. London: NICE, 2003. http://www.nice.org.uk/guidance/CG6 (accessed Nov 2006).
12. Fuchs K, Peipert J. First trimester Down syndrome screening: public health implications. Semin Perinatol 2005; 29: 267-271.
13. Simpson J. Choosing the best prenatal screening protocol. N Engl J Med 2005; 353: 2068-2070.
14. Neilson JP, Alfirevic Z. Optimising prenatal diagnosis of Down's syndrome. BMJ 2006; 332: 433-434.
15. Rose N. On the current dilemma of Down syndrome screening. Obstet Gynecol 2006; 107: 2-3.
16. Tyzack K, Wallace E. Down syndrome screening: what do health professionals know? Aust N Z J Obstet Gynaecol 2003; 43: 217-221.
17. Hadlow N, Hewitt B, Dickinson J, et al. Community-based screening for Down's syndrome in the first trimester using ultrasound and maternal serum biochemistry. BJOG 2005; 112: 1561-1564.
18. Mulvey S, Wallace E. Women's knowledge of and attitudes to first and second trimester screening for Down's syndrome. BJOG 2000; 107: 1302-1305.
19. Getz L, Kirkengen A. Ultrasound screening in pregnancy. Advancing technology, soft markers for fetal chromosomal aberrations, and unacknowledged ethical dilemmas. Soc Sci Med 2003; 56: 2045-2057.
20. Williams C, Sandall J, Lewando-Hundt G, et al. Women as moral pioneers? Experiences of first trimester antenatal screening. Soc Sci Med 2005; 61: 1983-1992.
21. Biggio J, Morris T, Owen J, Stringer J. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years. Am J Obstet Gynecol 2004; 190: 721-729.
22. Medical Services Advisory Committee. Nuchal translucency measurement in the first trimester of pregnancy for screening of trisomy 21 and other autosomal trisomies. Canberra: MSAC, 2003. http://www.health.gov.au/ internet/msac/publishing.nsf/Content/ref04-1/$FILE/msacref04.pdf (accessed Nov 2006).
23. Odibo A, Stamilio D, Nelson D, et al. A cost-effectiveness analysis of prenatal screening strategies for Down syndrome. Obstet Gynecol 2005; 106: 562-568.